Navigation Links
ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium
Date:7/28/2014

NEW YORK, July 28, 2014 /PRNewswire/ -- David Hardison, Ph.D., vice president of health services for ConvergeHEALTH by Deloitte, has been elected chairman of the board for the Clinical Data Interchange Standards Consortium, a non-profit working to establish common protocols around the use of clinical research data, particularly as it relates to electronic health records.

Hardison will work to continue CDISC's mission of collaborating with organizations across the research and health care arena in harmonizing practices related to the acquisition, exchange, submission and archiving of clinical data and metadata.  He previously served as CDISC's chairman from 2005 to 2007.

"We are pleased to have David chair the organization once again and bring his expertise in the field to our organization," said Dr. Rebecca Kush, president and chief executive officer of CDISC. "CDISC appreciates that ConvergeHEALTH supports the open-source development of data standards and innovation to improve medical research and interoperability in many areas of health care."

Hardison said his appointment reflects Deloitte's commitment to the importance of standards-based innovation in health care.  "I have been a champion of CDISC for many years and look forward to my continued support of the organization and its vision to 'inform patient care and safety through higher quality medical research.'"

Hardison has more than 30 years of experience in the biopharmaceutical and providers sectors, including executive and board-level roles related to information technology and performance improvement. 

Hardison will speak at the CDISC Asia-Pacific/Japan Interchange 2014 on July 31 in Tokyo, an event that runs from July 28 through Aug. 1.

About CDISC
CDISC is a 501(c)(3) global non-profit charitable organization with more than 300 supporting member organizations from across the clinical research and health care arenas. Through the efforts of volunteers around the globe, CDISC catalyzes productive collaboration to develop industry-wide data standards enabling the harmonization of clinical data and streamlining research processes from protocol through analysis and reporting, including the use of electronic health records to facilitate the collection of high quality research data. The CDISC standards and innovations can significantly decrease the time and cost of medical research and improve quality, thus contributing to the faster development of safer and more effective medical products and a learning health care system. The CDISC vision is to inform patient care and safety through higher quality medical research. For more information, visit http://www.cdisc.org/.

About ConvergeHEALTH by Deloitte
ConvergeHEALTH brings powerful, demonstrated analytics platforms and data models from Recombinant by Deloitte, advanced proprietary and open-source analytics, content and benchmarks through collaboration with industry leaders and deep experiences from Deloitte's Life Sciences and Health Care consulting practice to help our clients survive and thrive in the new paradigm of value-based, personalized medicine.  For more information, visit www.converge-health.com.

As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP.  Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.

Logo - http://photos.prnewswire.com/prnh/20120803/MM52028LOGO-a  


'/>"/>
SOURCE Deloitte
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer
2. DuPont Congratulates David Hula for Breaking Corn Yield World Record with Pioneer® Brand Hybrid P2088YHR in 2013 NCGA Corn Yield Contest
3. Barnet Dulaney Perkins Eye Center Regrets to Announce the Passing of David Dulaney, MD
4. Atlas Appoints David Whitaker as Operations Director
5. Dr. David R. Bassett Joins ActiGraph Scientific Advisory Board
6. David Julius Wins 2013 Dr. Paul Janssen Award for Biomedical Research
7. David Hooper Joins Evolution Marketing Research as Senior Director, Research
8. Can Science Really Get You Laid? The Shocking Truth About Dr. David Tan's "Desire System"
9. Dr. David Slaughter Launches Groundbreaking Cavity Prevention Program That Can Lower Decay Rates by 74%
10. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
11. David Smith Named Vice President of Operations for HealthTell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... -- Summary This report provides all the ... partnering interests and activities since 2010. Description The Partnering ... into the partnering activity of one of the world,s leading ... prepared upon purchase to ensure inclusion of the most up ... will be delivered in PDF format within 1 working day ...
(Date:3/28/2017)... March 28, 2017  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... of novel therapies for metabolic and endocrine disorders, today ... , Ph.D., will deliver a corporate presentation at H.C. ... Conference, being held April 3, 2017 at the St. ... for this presentation are as follows: ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic therapies for ... recent study published in STEM CELLS suggests that human neural stem cell (hNSC) ... to produce more neural cells. , Strategies involving transplantation of these cells ...
(Date:3/28/2017)... Triangle Park, NC (PRWEB) , ... March 28, ... ... development company engaged in the development of a new orally administered treatment for ... Advisory Board. , CEO John Didsbury states, “As we seek to uniquely treat ...
Breaking Biology Technology:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... SAN FRANCISCO , Feb. 13, 2017 /PRNewswire/ ... a centralized platform that is designed to enhance ... the latest release in the RSA Fraud & ... to enable organizations to leverage additional insights from ... anti-fraud tools to better protect their customers from ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):